Physician profile
Sarah Simpson
NPI 1669980579
$774.76
in general payments reported to CMS, 2019-2025
16 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.38 · 2022: $44.10 · 2023: $83.22 · 2024: $249 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $150.14 | 2025 | Epic, Freestyle Libre 3 |
| Bayer Healthcare Pharmaceuticals INC. | $127.24 | 2023-2025 | |
| Abbvie INC. | $125.40 | 2022-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $78.59 | 2024-2025 | Caplyta |
| Lilly USA, LLC | $58.77 | 2023-2024 | Mounjaro |
| Dexcom, INC. | $41.75 | 2022-2024 | Dexcom G6 Transmitter |
| Baxter Healthcare | $40.17 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $30.05 | 2025 | Airsupra, Farxiga |
| Novo Nordisk INC | $17.66 | 2025 | Ozempic, Rybelsus |
| Lundbeck LLC | $17.32 | 2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $16.98 | 2022 | |
| Glaxosmithkline, LLC. | $15.99 | 2024 | Trelegy Ellipta, Arexvy |
| Phathom Pharmaceuticals, INC. | $14.42 | 2025 | Voquezna |
| Exact Sciences Corporation | $13.96 | 2023 | Cologuard Collection Kit |
| Photonicare INC | $13.94 | 2025 | Otosight Middle Ear Scope |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $12.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.